[EXCLUSIVE] Key Takeaways from the Interview with Bernard Daymon, CEO of LYRA ETK

Vision, Innovation, and the Future of Implantology According to Our CEO

At LYRA ETK, we place biology and digital innovation at the heart of our approach. That’s what our CEO, Bernard Daymon, emphasized in a recent interview where he shared his strategic vision, the pillars of our development, and the innovations shaping the future of implantology.

A Clear Mission: Safely Restoring Smiles

Since taking the helm of LYRA ETK two years ago, Bernard Daymon has strengthened our mission:

To offer simple, safe, and accessible solutions by combining scientific excellence with standardized clinical protocols.

This mission targets three key audiences:

• Dentists, to whom we provide reliable, predictable, and effective tools.
• Laboratories, to streamline communication and ensure a smooth, secure workflow.
• Patients, as our top priority, with aesthetic, minimally invasive, and long-lasting treatments.

iPhysio®: Innovation for Everyday Practice

Among our most iconic innovations, Bernard Daymon highlights the iPhysio® protocol, a 3-in-1 solution that transforms clinical practice:

• The iPhysio® innovation serves as a healing abutment, an impression component, and a temporary prosthetic support.
• An anatomically designed shape guides soft tissue healing, promoting a natural and predictable emergence profile.
• Seamless digital integration thanks to digital libraries compatible with leading implant brands.

Clinical Results?

A 1-year follow-up study of 103 patients was published in the Journal of Dentistry with outstanding results. The device is also DDS certified and FDA approved, confirming its reliability.

iBone®: An Implant Designed for Biology

Another key innovation: the iBone® implant, embodying LYRA ETK’s philosophy.

Designed to respect bone biology, it:

• Reduces the amount of metal in the mouth by 34%,
• Provides 42% more contact surface thanks to an optimized thread design,
• Allows placement with low insertion torque (<50 Ncm), reducing bone stress by 42%.

With an average primary stability (ISQ 73), iBone® is suitable for all bone types (D1 to D4), with a digital selector that customizes the implant based on patient anatomy.

A Company Open to Collaboration

Bernard Daymon emphasizes one key point:

“We remain open to all digital ecosystems, to avoid locking practitioners or labs into closed systems.”

This is also why LYRA ETK chose to become a Gold Sponsor of DDS 2025, reinforcing its commitment to scientific research and knowledge sharing within the dental community.

See complete interview